Metacon invest €1.5 million into Helbio and increase its shareholding
Helbio Holdings has carried out a share capital increase of €1.5 million. Metacon AB subscribed for the full amount of the placement and was granted full allocation.
As a result, 14.087 new shares were issued at a subscription price of €106.48. Following the capital increase, Helbio Holdings capital is made up of 154,954 shares with a nominal value of €1 each, equating to a total share capital of €154,954. Metacon’s ownership in Helbio Holdings amounts to 56.63% post the new issuance of shares. Helbio Holdings S.A. owns 100% of Helbio S.A.
“We are happy with the result of the rights issue, the largest in the company’s history. The positive outcome will facilitate continued progress in the product development and increased production capacity for our products.” says, Xenophon Verykios, CEO of Helbio.
For further information, please contact CEO Christopher Tornblom, phone +44 7827 509544 or e-mail email@example.com
This information is information that Metacon AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 13:10 CET on August 26, 2019.
About Metacon AB (publ)
Metacon AB (publ) is an international energy technology company. It offers patented technology for cost efficient and environmentally friendly production of hydrogen, through a catalyst process, for the transportation, industrial, commercial- and residential real estate sector.
Additional information may be found at https://metacon.se | Twitter: @Metaconab | LinkedIn: https://www.linkedin.com/company/metaconab
Metacon AB, Dammbrovägen 1, SE-691 50 Karlskoga, SWEDEN | Tfn: +46 586 740080 | E-post: firstname.lastname@example.org